![]() ![]() ![]() Zhang and her lab to continue to develop novel bioinks for 3D- and 4D- printing," Fisher said. We are looking forward to a fruitful collaboration between our labs in the coming years." "This collaborative research will expand our fundamental understanding of iPSC cardiomyocyte development in a dynamic microenvironment for cardiac applications. "4D bioprinting is at the frontier of the field of bioprinting," Zhang said. Unlike ultraviolet or visible light, long-wavelength NIR light could efficiently penetrate the bioprinted structures without causing harm to surrounding cells. The research duo will use long-wavelength near-infrared (NIR) light to serve as the stimulus that prompts the 4D bioprinted structures into action. In this study, the bioinks, and the 4D structures they're used to create, are considered “reprogrammable" because they can be precisely controlled by external stimuli – in this case, by light – to contract and elongate on command in the same way that native heart muscle cells do with each and every heartbeat. The muscle cells they're working with – human induced pluripotent stem cell (iPSC) derived cardiomyocytes – represent a promising stem cell source for cardiovascular regeneration. Their main goal is to design novel and reprogrammable smart bioinks that can create dynamic 4D-bioprinted constructs to repair and control the muscle cells that make up the heart and pump blood throughout the body. GWU Department of Mechanical and Aerospace Engineering Associate Professor Lijie Grace Zhang and UMD Fischell Department of Bioengineering Professor and Chair John Fisher were recently awarded a joint $550,000 grant from the National Science Foundation to investigate 4D bioprinting of smart constructs for cardiovascular study. James Clark School of Engineering are working together to shed new light on this burgeoning field. Recognizing this, researchers at George Washington University (GWU) and the University of Maryland's A. One of the critical challenges impacting the field is the lack of advanced 4D-printable bioinks – material used to produce engineered live tissue using printing technology – that not only meet the requirements of 3D bioprinting, but also feature smart, dynamic capabilities to regulate cell behaviors and respond to changes in the environment wherever they're implanted in the body. This technology could be a game-changer for human health, particularly in pediatrics, where 4D-printed constructs could grow and change as children age, eliminating the need for future surgeries to replace tissues or scaffolds that fail to do the same.īut, 4D bioprinting technology is still young. Engineers apply 4D printing strategies to create constructs using biocompatible, responsive materials or cells that can grow or even change functionalities over time and in response to their environment. While 3D bioprinting can create 3D structures made of living cells, the final product is static – it cannot grow or change in response to changes in its environment.Ĭonversely, in 4D bioprinting, time is the fourth dimension. ![]() Thanks to advancements in 3D-printing technology, engineers have applied cutting-edge bioprinting techniques to create scaffolds and cardiac tissue that, once implanted, can quickly integrate with native tissues in the body. ![]() In recent years, scientists have looked to regenerative therapies – including those that use 3D-printed tissue – to repair damage done to the heart and restore cardiac function. Cardiovascular disease is the leading cause of mortality worldwide, accounting for nearly 18 million deaths each year, according to the World Health Organization. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |